Chai Discovery

Chai Discovery develops AI models that design antibodies and biologics from scratch, dramatically accelerating drug discovery. It’s applying large-scale model training to molecular design. The company aims to become a foundational AI layer for pharmaceutical R&D. “The team has led AI-for-biology programs at premier labs, co-invented protein language modelling, built state-of-the-art folding algorithms, and sold AI adopted by top-10 pharma companies. The company is backed by top-tier investors, including OpenAI, Thrive Capital, and many more.”